Status:
COMPLETED
A Patient Decision Aid for Method of Early Abortion: a Randomized Control Trial
Lead Sponsor:
Nova Scotia Health Authority
Collaborating Sponsors:
Dalhousie University
University of British Columbia
Conditions:
Abortion in First Trimester
Abortion Early
Eligibility:
FEMALE
Phase:
NA
Brief Summary
Introduction: There are two options for women seeking early pregnancy termination in Canada; either surgical or medication abortion. When making a decision about which option is best for them, patient...
Detailed Description
There are two options for women seeking early pregnancy termination in Canada; either surgical or medication abortion. Each offers unique benefits and drawback. When making a decision about which opti...
Eligibility Criteria
Inclusion
- person of reproductive age seeking termination of pregnancy, felt to be within the eligible period for a medication abortion (\<9 weeks or 63 days from last menstrual period), can provide consent, has access to internet and a valid email address and be able to read and speak English.
Exclusion
- Participants will be excluded from the four week follow up survey if they are subsequently found to be ineligible for medication abortion (pregnancy too advanced or if there are medical contraindications), if they miscarry spontaneously, or choose to continue their pregnancy.
Key Trial Info
Start Date :
May 5 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2024
Estimated Enrollment :
365 Patients enrolled
Trial Details
Trial ID
NCT05182008
Start Date
May 5 2022
End Date
April 1 2024
Last Update
February 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
QEII Health Sciences Center
Halifax, Nova Scotia, Canada, B3H 2Y9